347850 fundamentals
D&D PHARMATECH INC. financial statements, including revenue, expenses, and profit
The total revenue of 347850 for the last quarter is 5.06 B KRW, and it's 160.63% higher compared to the previous quarter. The net income of Q4 24 is -9.39 B KRW.
Q2 '23
Q3 '23
Q2 '24
Q3 '24
Q4 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: KRW
Q2 '23
Q3 '23
Q2 '24
Q3 '24
Q4 '24
TTM